Kyle O'Neil

Back Bay Life Science Advisors

Back Bay Life Science Advisors offers integrated strategy consulting and investment banking execution for the life sciences. We guide biotech, pharmaceutical, and medical technology companies and their investors on development, commercialization, growth, and maintenance of market share. Back Bay provides clear and unbiased advice and execution for the critical decisions that drive value. In 2023, Back Bay entered a strategic partnership with DNB Bank to provide healthcare companies with strategic guidance, M&A and partnering support and execution and capabilities in global capital markets and investment and commercial banking. Together, as an international collaboration, DNB and Back Bay Life Science Advisors offer unique support to companies along the full continuum of life science and healthcare development. Learn more: https://bit.ly/3MUKD9q